Literature DB >> 15411629

A new prothrombopenic drug, phenylindanedione.

L B JAQUES, E GORDON E LEPP.   

Abstract

Entities:  

Keywords:  BLOOD; PHENYLINDANEDIONE

Mesh:

Substances:

Year:  1950        PMID: 15411629      PMCID: PMC1821360     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Dicoumarol drugs and the problem of haemorrhage.

Authors:  L B JAQUES
Journal:  Can Med Assoc J       Date:  1959-11-15       Impact factor: 8.262

2.  Clinical evaluation of miradon.

Authors:  G KELLAWAY
Journal:  Br Med J       Date:  1958-10-11

3.  Vitamin K1 in the control of phenylindanedione-induced anticoagulant therapy.

Authors:  A ENGLISH; S R TOWNSEND; D G CAMERON
Journal:  Can Med Assoc J       Date:  1955-02-01       Impact factor: 8.262

4.  Phenylindanedione: a useful anticoagulant.

Authors:  S R TOWNSEND; K J FAY; J R DOWNING; R LAING; D G CAMERON
Journal:  Can Med Assoc J       Date:  1953-08       Impact factor: 8.262

5.  Therapeutic evaluation of a new anticoagulant, phenylindandione.

Authors:  W W COON; I F DUFF; P E HODGSON; E W DENNIS
Journal:  Ann Surg       Date:  1953-09       Impact factor: 12.969

6.  The mode of action of phenylindanedione.

Authors:  W WALKER; R B HUNTER
Journal:  J Clin Pathol       Date:  1954-08       Impact factor: 3.411

7.  The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.

Authors:  M TAGER
Journal:  Yale J Biol Med       Date:  1953-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.